The long-term outcome of cystinuria in Japan

被引:18
作者
Akakura, K
Egoshi, K
Ueda, T
Nozumi, K
Kotake, T
Masai, M
Ito, H
机构
[1] Chiba Univ, Sch Med, Dept Urol, Chuo Ku, Chiba 260, Japan
[2] Funabashi Clin, Funabashi, Chiba, Japan
[3] Teikyo Univ, Ichihara Hosp, Dept Urol, Ichihara, Japan
关键词
cystinuria; urolithiasis; medical treatment;
D O I
10.1159/000030294
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Recurrence of growth of urinary stone is frequently observed during the clinical course of cystinuria patients. The aim of the present study is to examine the long-term outcome of cystinuria in Japan and clarify the effects of medical treatment on urinary stone. Thirty-one patients with cystinuria who had been followed up longer than 6 months were included, The follow-up period was 6-264 months with a mean of 89.5 months. Stone event was defined as appearance of new stone or radiological evidence of stone growth. All patients were managed with forced hydration and urine alkalization, Twenty-eight patients were treated with administration of thiol such as D-penicillamine or alpha-mercaptopropionylglycine. Stone events per year ranged from 0 to 1.09 with a median of 0.09, Stone events per patient-year was 0.19 for all patients. The average urinary cystine concentration during treatment in the favorable outcome group (stone events per year < 0.3) was lower that that in the unfavorable outcome group (stone events per year greater than or equal to 0.3); 221.2 +/- 75.2 vs. 303.3 +/- 93.5 mg/l, although the difference was not statistically significant. Prognosis of urinary stone in Japanese patients with cystinuria was relatively good with large variation. The medical treatment to reduce urinary cystine concentration would be useful for the management of cystinuria.
引用
收藏
页码:86 / 89
页数:4
相关论文
共 18 条
[1]  
BERTRAN J, 1993, J BIOL CHEM, V268, P14842
[2]   GENETIC-HETEROGENEITY IN CYSTINURIA - THE SLC3A1 GENE IS LINKED TO TYPE-I BUT NOT TO TYPE-III CYSTINURIA [J].
CALONGE, MJ ;
VOLPINI, V ;
BISCEGLIA, L ;
ROUSAUD, F ;
DESANCTIS, L ;
BECCIA, E ;
ZELANTE, L ;
TESTAR, X ;
ZORZANO, A ;
ESTIVILL, X ;
GASPARINI, P ;
NUNES, V ;
PALACIN, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (21) :9667-9671
[3]   Medical treatment of cystinuria: Results of contemporary clinical practice [J].
Chow, GK ;
Streem, SB .
JOURNAL OF UROLOGY, 1996, 156 (05) :1576-1578
[4]   CLINICAL EFFECT OF CAPTOPRIL ON THE FORMATION AND GROWTH OF CYSTINE CALCULI [J].
COHEN, TD ;
STREEM, SB ;
HALL, P .
JOURNAL OF UROLOGY, 1995, 154 (01) :164-166
[5]   Cystine stones: The efficacy of percutaneous and shock wave lithotripsy [J].
Cranidis, AI ;
Karayannis, AA ;
Delakas, DS ;
Livadas, CE ;
Anezinis, PE .
UROLOGIA INTERNATIONALIS, 1996, 56 (03) :180-183
[6]   HETEROZYGOTES FOR CYSTINURIA [J].
CRAWHALL, JC ;
SAUNDERS, EP ;
THOMPSON, CJ .
ANNALS OF HUMAN GENETICS, 1966, 29 :257-+
[7]   TREATMENT OF CYSTINURIA [J].
DENT, CE ;
FRIEDMAN, M ;
GREEN, H ;
WATSON, LCA .
BMJ-BRITISH MEDICAL JOURNAL, 1965, 1 (5432) :403-+
[8]  
GASPARINI P, 1995, AM J HUM GENET, V57, P781
[9]  
HARRIS H., 1955, ANN HUMAN GENETICS, V19, P196, DOI 10.1111/j.1469-1809.1955.tb01344.x
[10]   Molecular genetics of cystinuria in French Canadians: Identification of four novel mutations in Type I patients [J].
Horsford, J ;
Saadi, I ;
Raelson, J ;
Goodyer, PR ;
Rozen, R .
KIDNEY INTERNATIONAL, 1996, 49 (05) :1401-1406